Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Miravant Medical Tech. (NasdaqNM:MRVT)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Recent Events
Aug  9Earnings Announcement
Location
336 Bollay Drive
Santa Barbara, CA 93117
Phone: (805) 685-9880
Fax: (805) 685-2959
Email: mail@miravant.com
Employees (last reported count): 144
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 32%
·Over the last 6 months:
 · one insider sell; 9,000  shares
  (0.2% of insider shares)
·Institutional: 17% (25% of float)
(64 institutions)
·Net Inst. Buying: 109.0K shares (+3.31%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Miravant Medical Technologies is developing light-activated drugs and associated devices for a medical procedure called photodynamic therapy. The Company has branded its proprietary version of photodynamic therapy as PhotoPoint. PhotoPoint therapy integrates the Company's drugs with its light-producing components and light-delivery devices to achieve a photochemical effect on targeted diseased cells and blood vessels. PhotoPoint therapy is a platform technology that has the potential to be a safe and effective treatment for a broad range of diseases, including those in ophthalmology, oncology, cardiology and dermatology. The Company is conducting a variety of pre-clinical studies in each of these areas and is supporting human clinical trials in ophthalmology with its lead drug candidate, SnET2 (tin ethyl etiopurpurin).
More from Market Guide: Expanded Business Description

Financial Summary
MRVT is engaged in the research and development of drugs and medical device products for use in photodynamic therapy, a procedure which uses light-activated drugs to achieve selective photochemical destruction of diseased cells. For the six months ended 6/30/01, revenues fell 12% to $2.6 million. Net loss fell 37% to $6.8 million. Results reflect lower license revenues due to the completion of certain preclinical studies, offset by lower R&D expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY1999 Pay

Gary Kledzik, Ph.D., 50
Chairman and CEO
$325K
David Mai, 55
Pres
250K
John Philpott, 39
CFO, Treasurer
175K
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:MRVTAs of 31-Aug-2001
Price and Volume
52-Week Low
on 4-Apr-2001
$6.00 
Recent Price$7.07 
52-Week High
on 1-Sep-2000
$25.625
Beta1.01 
Daily Volume (3-month avg)47.2K
Daily Volume (10-day avg)37.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-70.9%
52-Week Change
relative to S&P500
-61.0%
Share-Related Items
Market Capitalization$131.9M
Shares Outstanding18.7M
Float12.7M
Dividends & Splits
Annual Dividendnone 
Last Split: 3 for 2 on 8-Aug-1995
Per-Share Data
Book Value (mrq)-$0.34 
Earnings (ttm)-$1.19 
Earnings (mrq)-$0.11 
Sales (ttm)$0.23 
Cash (mrq)$0.71 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)30.92 
Income Statements
Sales (ttm)$4.23M
EBITDA (ttm)-$15.7M
Income available to common (ttm)-$22.0M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-76.78%
Return on Equity (ttm)-8228.53%
Financial Strength
Current Ratio (mrq)5.93 
Debt/EquityN/A 
Total Cash (mrq)$13.2M
Short Interest
As of 8-Aug-2001
Shares Short606.0K
Percent of Float4.8%
Shares Short
(Prior Month)
661.0K
Short Ratio21.64 
Daily Volume28.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.